Comment on ‘Cost effectiveness of collagen crosslinking for progressive keratoconus in the UK NHS’ – (Eye 30, 1150 (August 2016))
Comment on ‘Cost effectiveness of collagen crosslinking for progressive keratoconus in the UK NHS’ Eye 30, 1150 (August 2016). doi:10.1038/eye.2016.82 Authors: D A Godefrooij, G A de Wit, M J Mangen & R P L Wisse
Response to: Comment on ‘Cost effectiveness of collagen crosslinking for progressive keratoconus in the UK NHS’ – (Eye 30, 1152 (August 2016))
Response to: Comment on ‘Cost effectiveness of collagen crosslinking for progressive keratoconus in the UK NHS’ Eye 30, 1152 (August 2016). doi:10.1038/eye.2016.85 Authors: A Salmon, D Chalk, K Stein & A Frost
Predictors of stereoacuity outcome in visually mature subjects with exotropia – (Eye 30, 1154 (August 2016))
Predictors of stereoacuity outcome in visually mature subjects with exotropia Eye 30, 1154 (August 2016). doi:10.1038/eye.2016.151 Authors: F Koç & N Sefi-Yurdakul
Triple bottom line: sustainability in amblyopia care – (Eye 30, 1029 (August 2016))
Triple bottom line: sustainability in amblyopia care Eye 30, 1029 (August 2016). doi:10.1038/eye.2016.116 Authors: R Thomas, L Brocklesby, A Coleman, V Cuchhadia, D Dunham, S Glaze, P Khandelwal & A Dahlmann-Noor
Associations of retinal artery occlusion and retinal vein occlusion to mortality, stroke, and myocardial infarction: a systematic review – (Eye 30, 1031 (August 2016))
Associations of retinal artery occlusion and retinal vein occlusion to mortality, stroke, and myocardial infarction: a systematic review Eye 30, 1031 (August 2016). doi:10.1038/eye.2016.111 Authors: S C Y Woo, G Y H Lip & P L Lip